covid 19 News and Research

RSS

The transmission dynamics of SARS-CoV2 Omicron variant

In a recent study posted to the medRxiv* preprint server, researchers developed a coronavirus disease (COVID-19) model-inference system in South Africa to determine transmission dynamics and immune evasion associated with severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV-2) Omicron variant.

22 Dec 2021

New allocation model to optimize the distribution of COVID-19 vaccines, treatments

Lulu Kang, associate professor of applied mathematics at Illinois Institute of Technology and a team of researchers from the University of Illinois Chicago put a new twist on traditional resource allocation models to optimize the distribution of COVID-19 vaccines, treatments, testing supplies, and other related resources, publishing their findings, "Fair and Diverse Allocation of Scarce Resources," in Socio-Economic Planning Sciences.

22 Dec 2021

Researchers explore problematic smartphone use during COVID-19 pandemic

A new survey study has identified links between problematic smartphone use and low sense of control, repetitive thinking, and fear of missing out (FOMO) during the COVID-19 pandemic in the spring of 2021, suggesting possible avenues for reducing the severity of such use.

22 Dec 2021

How the SARS-CoV-2 Delta variant grew to dominate the UK epidemic

Researchers examine SARS-CoV-2 genomes in England to evaluate the effectiveness of COVID-19 policies.

22 Dec 2021

Decline in protection against SARS-CoV-2 Omicron in prior infected and fully vaccinated

In a recent study posted to the medRxiv* preprint server, researchers investigated the distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants among coronavirus disease 2019 (COVID-19) positive individuals who were either naive, fully vaccinated, or had a previous infection to further investigate possible escape from vaccine- or infection-induced immunity by Omicron compared to Delta.

22 Dec 2021

Scientists develop methods to quantify the transmissibility of new COVID-19 variants

As the discovery of the new omicron variant illustrates, new COVID-19 variants will continue to regularly emerge.

22 Dec 2021

World leaders meet to discuss about COVID-19 vaccines, therapeutics and diagnostics

The heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization held high-level consultations with Gavi and UNICEF on 17 December, 2021 aimed at increasing the use of COVID-19 vaccines and other critical medical countermeasures in low-income (LIC) and lower middle-income (LMIC) countries and supporting countries to be better prepared, resourced, and ready to roll out vaccines.

22 Dec 2021

T-cell response to Omicron after an mRNA COVID vaccine booster

In a recent prospective observational study posted to the medRxiv* preprint server, researchers determined Omicron variant-associated T cell responses before and after a third dose of messenger ribonucleic acid (mRNA) vaccination against coronavirus disease (COVID-19) in anti-CD20-treated multiple sclerosis (MS) patients.

22 Dec 2021

All carers are encouraged to 'Get Boosted Now'

A new study, published today by the University of Birmingham and UCL, adds further evidence to the importance of a booster vaccine for both carers and care home residents as they are encouraged to Get Boosted Now.

22 Dec 2021

Study assesses the impact of COVID-19 pandemic on dental faculty well-being

As the COVID-19 pandemic forced the world to withdraw for safety in 2020, faculty at dental schools did not report significant decreases in measures of their well-being, according to results from a study led by Carlos S. Smith, D.D.S., at Virginia Commonwealth University School of Dentistry.

22 Dec 2021

More breakthrough infections but less severe COVID-19 with Omicron

In a recent study posted to the bioRxiv* pre-print server, an international team of researchers reported the occurrence of coronavirus disease 2019 (COVID-19) breakthrough infections (BTIs) among health care workers (HCWs) participating in a phase III vaccine trial in Sisonke, South Africa.

22 Dec 2021

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

A recent review article discusses recent advances in protein-based nanoparticle vaccines against SARS-CoV-2.

22 Dec 2021

UK reaches milestone of 30 million boosters as the drive continues to Get Boosted Now

More than 30 million people, over 56% of adults in the UK, have now had their COVID-19 booster during a record-breaking week for top-up jabs.

22 Dec 2021

COVID can affect sperm quality for three months

Researchers determine whether SARS-CoV-2 could cross the blood-testis barrier and be detected in human semen after infection.

22 Dec 2021

How COVID vaccines protected Americans against the Delta variant

A new study analyzed the COVID-19 breakthrough case and death rates among fully vaccinated individuals who were 12 years of age or above.

22 Dec 2021

rVSV-based bivalent vaccine against SARS-CoV-2 delta variant and influenza

Researchers developed four distinct recombinant vesicular stomatitis virus (rVSV)-based bivalent vaccines against SARS-CoV-2 and influenza virus.

22 Dec 2021

MHRA approves new formulation of Pfizer BioNTech COVID-19 vaccine for 5-11 year olds

A new age-appropriate formulation of the Pfizer BioNTech COVID-19 vaccine (Comirnaty) for use in children aged 5 to 11 years old has been approved today by the Medicines and Healthcare products Regulatory Agency (MHRA) after finding that it is safe and effective.

22 Dec 2021

covid 19 News and Research

The transmission dynamics of SARS-CoV2 Omicron variant

New allocation model to optimize the distribution of COVID-19 vaccines, treatments

Researchers explore problematic smartphone use during COVID-19 pandemic

How the SARS-CoV-2 Delta variant grew to dominate the UK epidemic

Decline in protection against SARS-CoV-2 Omicron in prior infected and fully vaccinated

Scientists develop methods to quantify the transmissibility of new COVID-19 variants

World leaders meet to discuss about COVID-19 vaccines, therapeutics and diagnostics

T-cell response to Omicron after an mRNA COVID vaccine booster

All carers are encouraged to 'Get Boosted Now'

Study assesses the impact of COVID-19 pandemic on dental faculty well-being

More breakthrough infections but less severe COVID-19 with Omicron

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

UK reaches milestone of 30 million boosters as the drive continues to Get Boosted Now

COVID can affect sperm quality for three months

How COVID vaccines protected Americans against the Delta variant

rVSV-based bivalent vaccine against SARS-CoV-2 delta variant and influenza

MHRA approves new formulation of Pfizer BioNTech COVID-19 vaccine for 5-11 year olds

Role of novel SARS-CoV-2-derived svRNAs and the involvement of tRF in COVID-19

Extended interval between second and third vaccination beneficial against SARS-CoV-2 Omicron variant

Scientists identify a panel of nanobodies with good neutralizing efficacy against SARS-CoV-2 variants of concern

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News